These findings, for the first time, demonstrate that TRPM7 exerts a crucial role in hypoxia-related signaling in androgen-independent prostate cancer cells, and suppression of TRPM7 promotes the degradation of HIF-1α under hypoxic conditions in androgen-independent prostate cancer cells. Here, TRPM7 is linked to prostate cancer.